Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2021-12-16 2021-12-16
Drug Identification Number 02350505 02350505
Brand name TERAZOSIN TERAZOSIN
Common or Proper name TERAZOSIN TERAZOSIN
Company Name SANIS HEALTH INC SANIS HEALTH INC
Ingredients TERAZOSIN TERAZOSIN
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code G04CA G04CA
ATC description DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2022-03-01 2022-03-01
Actual discontinuation date
Remaining supply date
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments